These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 23462208)

  • 41. Long-term survival of patients after ipilimumab and hypofractionated brain radiotherapy for brain metastases of malignant melanoma: sequence matters.
    Schmidberger H; Rapp M; Ebersberger A; Hey-Koch S; Loquai C; Grabbe S; Mayer A
    Strahlenther Onkol; 2018 Dec; 194(12):1144-1151. PubMed ID: 30298365
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Malignant melanoma brain metastases: Treatment results and prognostic factors--a single-center retrospective study.
    Ostheimer C; Bormann C; Fiedler E; Marsch W; Vordermark D
    Int J Oncol; 2015; 46(6):2439-48. PubMed ID: 25891163
    [TBL] [Abstract][Full Text] [Related]  

  • 43. BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis.
    Patel KR; Chowdhary M; Switchenko JM; Kudchadkar R; Lawson DH; Cassidy RJ; Prabhu RS; Khan MK
    Melanoma Res; 2016 Aug; 26(4):387-94. PubMed ID: 27223498
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcome predictors of Gamma Knife surgery for melanoma brain metastases. Clinical article.
    Liew DN; Kano H; Kondziolka D; Mathieu D; Niranjan A; Flickinger JC; Kirkwood JM; Tarhini A; Moschos S; Lunsford LD
    J Neurosurg; 2011 Mar; 114(3):769-79. PubMed ID: 20524829
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety and clinical activity of ipilimumab in melanoma patients with brain metastases: retrospective analysis of data from a phase 2 trial.
    Weber JS; Amin A; Minor D; Siegel J; Berman D; O'Day SJ
    Melanoma Res; 2011 Dec; 21(6):530-4. PubMed ID: 22051508
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peri-SRS Administration of Immune Checkpoint Therapy for Melanoma Metastatic to the Brain: Investigating Efficacy and the Effects of Relative Treatment Timing on Lesion Response.
    Yusuf MB; Amsbaugh MJ; Burton E; Chesney J; Woo S
    World Neurosurg; 2017 Apr; 100():632-640.e4. PubMed ID: 28179176
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: Patterns of care and treatment outcomes.
    Gabani P; Fischer-Valuck BW; Johanns TM; Hernandez-Aya LF; Keller JW; Rich KM; Kim AH; Dunn GP; Robinson CG; Chicoine MR; Huang J; Abraham CD
    Radiother Oncol; 2018 Aug; 128(2):266-273. PubMed ID: 29960685
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases.
    Varlotto JM; Flickinger JC; Niranjan A; Bhatnagar A; Kondziolka D; Lunsford LD
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1125-32. PubMed ID: 15990018
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic factors for overall survival after radiosurgery for brain metastases from melanoma.
    Marcus DM; Lowe M; Khan MK; Lawson DH; Crocker IR; Shelton JW; Melton A; Maynard N; Delman KA; Carlson GW; Rizzo M
    Am J Clin Oncol; 2014 Dec; 37(6):580-4. PubMed ID: 23428955
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial.
    Di Giacomo AM; Ascierto PA; Pilla L; Santinami M; Ferrucci PF; Giannarelli D; Marasco A; Rivoltini L; Simeone E; Nicoletti SV; Fonsatti E; Annesi D; Queirolo P; Testori A; Ridolfi R; Parmiani G; Maio M
    Lancet Oncol; 2012 Sep; 13(9):879-86. PubMed ID: 22894884
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The treatment of brain metastases from malignant melanoma.
    Douglas JG; Margolin K
    Semin Oncol; 2002 Oct; 29(5):518-24. PubMed ID: 12407517
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stereotactic radiosurgery with or without whole brain radiotherapy for patients with a single radioresistant brain metastasis.
    Clarke JW; Register S; McGregor JM; Grecula JC; Mayr NA; Wang JZ; Li K; Gupta N; Kendra KL; Olencki TE; Cavaliere R; Sarkar A; Lo SS
    Am J Clin Oncol; 2010 Feb; 33(1):70-4. PubMed ID: 19652578
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Linac radiosurgery for brain metastasis of melanoma.
    Noël G; Simon JM; Valery CA; Cornu P; Boisserie G; Ledu D; Hasboun D; Tep B; Delattre JY; Marsault C; Baillet F; Mazeron JJ
    Stereotact Funct Neurosurg; 2002; 79(3-4):245-55. PubMed ID: 12890983
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stereotactic radiosurgery for 318 brain metastases in a single Australian centre: the impact of histology and other factors.
    Sia J; Paul E; Dally M; Ruben J
    J Clin Neurosci; 2015 Feb; 22(2):303-7. PubMed ID: 25304434
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Response of intracranial melanoma metastases to stereotactic radiosurgery.
    Gieger M; Wu JK; Ling MN; Wazer D; Tsai JS; Engler MJ
    Radiat Oncol Investig; 1997; 5(2):72-80. PubMed ID: 9303060
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy.
    Ahmed KA; Stallworth DG; Kim Y; Johnstone PA; Harrison LB; Caudell JJ; Yu HH; Etame AB; Weber JS; Gibney GT
    Ann Oncol; 2016 Mar; 27(3):434-41. PubMed ID: 26712903
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical outcomes of melanoma brain metastases treated with nivolumab and ipilimumab alone versus nivolumab and ipilimumab with stereotactic radiosurgery.
    Tang JD; Mills MN; Nakashima J; Dohm AE; Khushalani NI; Forsyth PA; Vogelbaum MA; Wuthrick EJ; Yu HM; Oliver DE; Liu JKC; Ahmed KA
    J Neurooncol; 2024 Feb; 166(3):431-440. PubMed ID: 38310157
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcome Evaluation of Patients with Limited Brain Metastasis From Malignant Melanoma, Treated with Surgery, Radiation Therapy, and Targeted Therapy.
    Pessina F; Navarria P; Tomatis S; Cozzi L; Franzese C; Di Guardo L; Ascolese AM; Reggiori G; Franceschini D; Del Vecchio M; Bello L; Scorsetti M
    World Neurosurg; 2017 Sep; 105():184-190. PubMed ID: 28578123
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biochemotherapy of metastatic melanoma in patients with or without recently diagnosed brain metastases.
    Majer M; Jensen RL; Shrieve DC; Watson GA; Wang M; Leachman SA; Boucher KM; Samlowski WE
    Cancer; 2007 Sep; 110(6):1329-37. PubMed ID: 17623835
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radiosurgery alone for 1-3 newly-diagnosed brain metastases from melanoma: impact of dose on treatment outcomes.
    Rades D; Sehmisch L; Huttenlocher S; Blank O; Hornung D; Terheyden P; Gliemroth J; Schild SE
    Anticancer Res; 2014 Sep; 34(9):5079-82. PubMed ID: 25202094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.